Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has issued a decision amending the marketing ...

Children aged 6 months to 12 years are the main spreaders of respiratory syncytial virus (RSV) infections within their ...

The Malinauskas Labor Government is keeping South Australian babies safe from Respiratory Syncytial Virus (RSV) this winter, with a long-acting ...

Historically, RSV has been studied mainly in infants and older adults, but recent research shows that it also poses a ...

Abrysvo, which is now the first maternal RSV vaccine to be prequalified by the organisation, aims to prevent RSV-associated ...

In primary care settings, the burden of RSV on young children and their guardians often varied between the countries of ...

The Royal Australian College of GPs (RACGP) has thrown its support behind Victoria's infant RSV vaccine program. Respiratory syncytial virus, or RSV ...

These conditions may also give rise to several other uncomfortable symptoms ... Young children who are especially vulnerable to serious illness from RSV may also be given an injection during ...

The European Commission approved Pfizer's respiratory syncytial virus vaccine for the prevention of lower respiratory tract ...

Pfizer’s RSV vaccine Abrysvo receives European approval to help protect adults aged 18-59 against RSV lower respiratory tract disease: New York Wednesday, April 2, 2025, 09:00 H ...